Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2025-12-24 @ 11:21 PM
NCT ID:
NCT03757156
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 19-80 years old
* Subjects who are taking for more than 12 months
* Subjects with moderate or high cardiovascular risk based on cardiovascular risk classification of 2015 Korea Society of Lipidology And Atherosclerosis guideline or 2004 American Heart Association guideline: 1) moderate risk: people with ≥2 major risk factors, 2) high risk: people with carotid atherosclerosis, abdominal aortic aneurysm, or diabetes, who is taking statin
* Subjects who voluntarily participate in the study and sign informed consent form
Exclusion Criteria:
* Subjects with a history of major cardiovascular disease confirmed by medical history and medical history; myocardial infarction, angina pectoris, coronary angioplasty, coronary artery bypass surgery, peripheral vascular disease, ischemic stroke, transient ischemic attack
* Subjects has any contraindication to use of aspirin or hypersensitivity to aspirin
* Subjects with atrial fibrillation
* Subjects who are taking anti-platelet agents other than aspirin or anticoagulants
* Subjects who have been diagnosed with cancer within the last 5 years
* Pregnant women or those who have pregnancy plan after enrolling in this study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
80 Years
Study:
NCT03757156
Study Brief:
Protocol Section:
NCT03757156